Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trialsMatteo Monami, Edoardo Mannucci, Ilaria Dicembrini et al.|Diabetes Obesity and Metabolism|2013Cited by 172